[
  {
    "ts": null,
    "headline": "How Recent Developments Are Shaping the Gilead Sciences Investment Story",
    "summary": "Recent analyst updates have led to a slight increase in Gilead Sciences’ fair value price target, moving from $127.23 to $129.51. This change is supported by renewed confidence in the company’s performance and potential, along with a minor uptick in perceived investment risk. Stay tuned to see how you can keep up with evolving perspectives in this dynamic narrative. Stay updated as the Fair Value for Gilead Sciences shifts by adding it to your watchlist or portfolio. Alternatively, explore...",
    "url": "https://finnhub.io/api/news?id=4bfaa417e570d7cb71acf3418fcfefc04001afd7bb100e3554651599df2f1d41",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762639986,
      "headline": "How Recent Developments Are Shaping the Gilead Sciences Investment Story",
      "id": 137384600,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Recent analyst updates have led to a slight increase in Gilead Sciences’ fair value price target, moving from $127.23 to $129.51. This change is supported by renewed confidence in the company’s performance and potential, along with a minor uptick in perceived investment risk. Stay tuned to see how you can keep up with evolving perspectives in this dynamic narrative. Stay updated as the Fair Value for Gilead Sciences shifts by adding it to your watchlist or portfolio. Alternatively, explore...",
      "url": "https://finnhub.io/api/news?id=4bfaa417e570d7cb71acf3418fcfefc04001afd7bb100e3554651599df2f1d41"
    }
  }
]